PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from July 1, 2022 until 48 hours from the publication of the audited financial results for Financial year ended June 30, 2022. Kindly take the same on record. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Dear Sir, We would like to submit the notice of the Postal Ballot with respect to the Company's proposal for seeking approval of the Members for the resolution mentioned in the notice. Kindly take the above on record and acknowledge the receipt. Thanking you.
Star MNC: Strong comeback for PGHH despite challenges posed by Covid-19
The company delivered profitable double-digit growth
P&G Hygiene and Health Care net profit rises 4.6% to Rs 102.85 cr in Q3
Procter & Gamble Hygiene and Health Care Ltd on Thursday reported a 4.59 per cent increase in its net profit to Rs 102.85 crore for the third quarter ended March 2022. The company, which follows July-June financial year, had posted a net profit of Rs 98.33 crore in the corresponding period last year, Procter & Gamble Hygiene and Health Care Ltd said in a regulatory filing. Its revenue from operations rose 28.11 per cent to Rs 973.26 crore during the period under review against Rs 759.66 crore in the January-March period last year. Procter & Gamble's profit was driven by a continued focus on productivity and a one-time hurt due to retrospective tax law change, the company said in an earnings statement. "Excluding this one-time impact, PAT was up 20 per cent vs year ago, despite commodity inflation," it said. Its total expenses were at Rs 828.19 crore, up 28.36 per cent against Rs 645.18 crore. Procter & Gamble Hygiene and Health Care Managing Director Madhusudan Gopalan Q4FY22 Quarterly Result Announced for Procter & Gamble Hygiene & Healthcare Ltd.
Personal Products company Procter & Gamble Hygiene & Healthcare declares Q4FY22 result: Procter & Gamble Hygiene and Health Care Ltd. delivered sales of Rs 973 crores, up 28% vs year ago driven by strong brand fundamentals, strength of its trusted product portfolio, strong retail execution and a one-time other income during the quarter from intercompany sale of inventory. Excluding the one-time income, comparable sales are up 17% vs year ago. Profit After Tax (PAT) was Rs 103 crores, up 5% driven by continued focus on productivity and a one-time hurt due to retrospective tax law change. Excluding this one-time impact, PAT was up 20% vs year ago, despite commodity inflation Madhusudan Gopalan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, “In a challenging market environment, we recorded strong double-digit sales growth driven by strong brand fundamentals and improved market execution. Excluding the one-time impact, our productivity efforts led to a strong double digit profit growth. As we navigate the challenging cost environment, we will continue to focus on improving productivity by leveraging advertising and promotion analytics, strengthening our product mix and driving supply chain efficiencies. In the long-term, we will continue to focus on driving balanced top and bottom-line growth enabled by our superiority strategy, improving productivity, leading constructive disruption, and strengthening our organization and culture.” Result PDF PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Unaudited Financial Results For The Quarter Ended March 31, 2022
We are pleased to inform you that at a meeting of the Board of Directors of the Company held today (commenced at 12.30 pm and ended at 1.30 pm), the Unaudited Financial Results for the quarter ended March 31, 2022 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended March 31, 2022; b. Press Release; c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended March 31, 2022 furnished by Statutory Auditors of the Company; and Kindly take the same on record and oblige. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended March 31, 2022
We are pleased to inform you that at a meeting of the Board of Directors of the Company held today (commenced at 12.30 pm and ended at 1.30 pm), the Unaudited Financial Results for the quarter ended March 31, 2022 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended March 31, 2022; b. Press Release; c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended March 31, 2022 furnished by Statutory Auditors of the Company; and Kindly take the same on record and oblige. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we inform you that we have been informed by our Registrars and Share Transfer Agents, Link Intime India Private Limited on 27/04/2022, about the issue of duplicate Share certificate to the shareholder mentioned in attached letter. We request you to take the same on record.
Procter Gamble profits rise on higher pricing
Maker of the Tide, Old Spice and Crest brands, PG has been buffeted by the economy-wide surge in commodity prices and freight service costs, most recently exacerbated by the Russian invasion of Ukraine. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Announcement under Regulation 30 (LODR)-Resignation of Managing Director
Mr. Madhusudan Gopalan, Managing Director is going to take on an important leadership role within P&G as Senior Vice President - Grooming & Oral Care, P&G Japan & Korea, and has tendered his resignation as Managing Director of the Company effective June 30, 2022. Kindly take the same on record and oblige.